Eleftherios P. Diamandis - Publications

Laboratory Medicine and Pathobiology University of Toronto, Toronto, ON, Canada 
Molecular Biology, Biochemistry

261 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Vasiliou SK, Diamandis EP. Androgen receptor: A promising therapeutic target in breast cancer. Critical Reviews in Clinical Laboratory Sciences. 1-24. PMID 30821186 DOI: 10.1080/10408363.2019.1575643  0.56
2019 Dimitrakopoulos L, Prassas I, Sieuwerts AM, Diamandis EP, Martens JWM, Charames GS. Proteome-wide onco-proteogenomic somatic variant identification in ER-positive breast cancer. Clinical Biochemistry. PMID 30684468 DOI: 10.1016/j.clinbiochem.2019.01.005  1
2019 Schiza C, Korbakis D, Jarvi K, Diamandis EP, Drabovich AP. Identification of TEX101-associated Proteins Through Proteomic Measurement of Human Spermatozoa Homozygous for the Missense Variant rs35033974. Molecular & Cellular Proteomics : McP. 18: 338-351. PMID 30429210 DOI: 10.1074/mcp.RA118.001170  0.52
2018 Muytjens CMJ, Yu Y, Diamandis EP. Functional proteomic profiling reveals KLK13 and TMPRSS11D as active proteases in the lower female reproductive tract. F1000research. 7: 1666. PMID 30647911 DOI: 10.12688/f1000research.16255.1  0.64
2018 Music M, Prassas I, Diamandis EP. Optimizing cancer immunotherapy: Is it time for personalized predictive biomarkers? Critical Reviews in Clinical Laboratory Sciences. 1-14. PMID 30277835 DOI: 10.1080/10408363.2018.1499706  1
2018 Begcevic I, Tsolaki M, Brinc D, Brown M, Martinez-Morillo E, Lazarou I, Kozori M, Tagaraki F, Nenopoulou S, Gkioka M, Lazarou E, Lim B, Batruch I, Diamandis EP. Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer's disease progression. F1000research. 7: 1012. PMID 30191060 DOI: 10.12688/f1000research.15095.1  0.92
2018 Diamandis EP, Scorilas A, Prassas I, Plebani M. The International Society for Enzymology: a glorious history, a golden legacy. Clinical Chemistry and Laboratory Medicine. PMID 30157030 DOI: 10.1515/cclm-2018-0766  1
2018 Schiza C, Korbakis D, Panteleli E, Jarvi K, Drabovich AP, Diamandis EP. Discovery of a human testis-specific protein complex TEX101-DPEP3 and selection of its disrupting antibodies. Molecular & Cellular Proteomics : McP. PMID 30097533 DOI: 10.1074/mcp.RA118.000749  0.52
2018 Filippou PS, Ren AH, Soosaipillai A, Papaioannou MD, Korbakis D, Safar R, Diamandis EP, Conner J. Expression profile of human tissue kallikrein 15 provides preliminary insights into its roles in the prostate and testis. Clinical Biochemistry. PMID 29958881 DOI: 10.1016/j.clinbiochem.2018.06.017  0.64
2018 Filippou PS, Ren AH, Bala S, Papaioannou MD, Brinc D, Prassas I, Karakosta T, Diamandis EP. Biochemical characterization of human tissue kallikrein 15 and examination of its potential role in cancer. Clinical Biochemistry. PMID 29928903 DOI: 10.1016/j.clinbiochem.2018.06.007  1
2018 Filippou PS, Ren AH, Korbakis D, Dimitrakopoulos L, Soosaipillai A, Barak V, Frenkel S, Pe'er J, Lotem M, Merims S, Molina R, Blasutig I, Bogdanos DP, Diamandis EP. Exploring the potential of mucin 13 (MUC13) as a biomarker for carcinomas and other diseases. Clinical Chemistry and Laboratory Medicine. PMID 29768245 DOI: 10.1515/cclm-2018-0139  0.64
2018 Leung F, Bernardini MQ, Liang K, Batruch I, Rouzbahman M, Diamandis EP, Kulasingam V. Unraveling endometriosis-associated ovarian carcinomas using integrative proteomics. F1000research. 7: 189. PMID 29721309 DOI: 10.12688/f1000research.13863.1  0.92
2018 Begcevic I, Brinc D, Dukic L, Simundic AM, Zavoreo I, Basic Kes V, Martínez-Morillo E, Batruch I, Drabovich AP, Diamandis EP. Targeted mass spectrometry-based assays for relative quantification of thirty brain-related proteins and their clinical applications. Journal of Proteome Research. PMID 29708756 DOI: 10.1021/acs.jproteome.7b00768  0.92
2018 Begcevic I, Brinc D, Brown M, Martinez-Morillo E, Goldhardt O, Grimmer T, Magdolen V, Batruch I, Diamandis EP. Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach. Journal of Proteomics. PMID 29684683 DOI: 10.1016/j.jprot.2018.04.027  0.92
2018 Di Meo A, Wang C, Cheng Y, Diamandis EP, Yousef GM. The miRNA-kallikrein interaction: a mosaic of epigenetic regulation in cancer. Biological Chemistry. PMID 29604203 DOI: 10.1515/hsz-2018-0112  0.76
2018 Reuning U, Magdolen V, Courty Y, Clements JA, Yousef GM, Scorilas A, Talieri M, Diamandis EP. Manfred Schmitt (1947-2018). Biological Chemistry. PMID 29601294 DOI: 10.1515/hsz-2018-0184  0.76
2018 Meo AD, Saleeb R, Wala SJ, Khella HW, Ding Q, Zhai H, Krishan K, Krizova A, Gabril M, Evans A, Brimo F, Pasic MD, Finelli A, Diamandis EP, Yousef GM. A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization. Oncotarget. 9: 2092-2104. PMID 29416756 DOI: 10.18632/oncotarget.23162  0.76
2018 Oikonomopoulou K, Diamandis EP, Hollenberg MD, Chandran V. Proteinases and their receptors in inflammatory arthritis: an overview. Nature Reviews. Rheumatology. PMID 29416136 DOI: 10.1038/nrrheum.2018.17  0.56
2018 Patra K, Soosaipillai A, Sando SB, Lauridsen C, Berge G, Møller I, Grøntvedt GR, Bråthen G, Begcevic I, Moussaud S, Minthon L, Hansson O, Diamandis EP, White LR, Nielsen HM. Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease. Alzheimer's Research & Therapy. 10: 9. PMID 29378650 DOI: 10.1186/s13195-018-0336-4  0.64
2017 Kulasingam V, Prassas I, Diamandis EP. Towards personalized tumor markers. Npj Precision Oncology. 1: 17. PMID 29872704 DOI: 10.1038/s41698-017-0021-2  1
2017 Mahendran SM, Oikonomopoulou K, Diamandis EP, Chandran V. Synovial fluid proteomics in the pursuit of arthritis mediators: An evolving field of novel biomarker discovery. Critical Reviews in Clinical Laboratory Sciences. 54: 495-505. PMID 29202618 DOI: 10.1080/10408363.2017.1408561  0.56
2017 Dimitrakopoulos L, Prassas I, Diamandis EP, Charames GS. Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction. Critical Reviews in Clinical Laboratory Sciences. 1-19. PMID 29025326 DOI: 10.1080/10408363.2017.1384446  1
2017 Muytjens CMJ, Yu Y, Diamandis EP. Discovery of Antimicrobial Peptides in Cervical-vaginal Fluid from Healthy Non-pregnant Women Via an Integrated Proteome and Peptidome Analysis. Proteomics. PMID 28941238 DOI: 10.1002/pmic.201600461  0.64
2017 Farkona S, Soosaipillai A, Filippou P, Korbakis D, Serra S, Rückert F, Diamandis EP, Blasutig IM. Generation of monoclonal antibodies and development of an immunofluorometric assay for the detection of CUZD1 in tissues and biological fluids. Clinical Biochemistry. PMID 28746862 DOI: 10.1016/j.clinbiochem.2017.07.012  0.64
2017 Forse CL, Rahimi M, Diamandis EP, Assarzadegan N, Dawson H, Grin A, Kennedy E, O'Connor B, Messenger DE, Riddell RH, Kirsch R, Karagiannis GS. HtrA3 stromal expression is correlated with tumor budding in stage II colorectal cancer. Experimental and Molecular Pathology. PMID 28716573 DOI: 10.1016/j.yexmp.2017.07.002  0.92
2017 Korbakis D, Soosaipillai A, Diamandis EP. Study of kallikrein-related peptidase 6 (KLK6) and its complex with α1-antitrypsin in biological fluids. Clinical Chemistry and Laboratory Medicine. PMID 28672746 DOI: 10.1515/cclm-2017-0017  0.64
2017 Delaunay T, Deschamps L, Haddada M, Walker F, Soosaipillai A, Soualmia F, El Amri C, Diamandis EP, Brattsand M, Magdolen V, Darmoul D. Aberrant expression of kallikrein-related peptidase 7 is correlated to human melanoma aggressiveness by stimulating cell migration and invasion. Molecular Oncology. PMID 28636767 DOI: 10.1002/1878-0261.12103  0.64
2017 Cretu D, Gao L, Liang K, Soosaipillai A, Diamandis EP, Chandran V. Novel serum biomarkers differentiate psoriatic arthritis from psoriasis without psoriatic arthritis. Arthritis Care & Research. PMID 28586166 DOI: 10.1002/acr.23298  0.64
2017 Filippou PS, Farkona S, Brinc D, Yu Y, Prassas I, Diamandis EP. Biochemical and Functional Characterization of the Human Tissue Kallikrein 9. The Biochemical Journal. PMID 28559305 DOI: 10.1042/BCJ20170174  1
2017 Nasser NJ, Thoms J, Soosaipillai A, Pintilie M, Wang R, Diamandis EP, Bristow RG. Human tissue Kallikreins: Blood levels and response to radiotherapy in intermediate risk prostate cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28427756 DOI: 10.1016/j.radonc.2017.03.023  0.64
2017 Briollais L, Ozcelik H, Xu J, Kwiatkowski M, Lalonde E, Sendorek DH, Fleshner NE, Recker F, Kuk C, Olkhov-Mitsel E, Juvet T, Prassas I, Trachtenberg J, Toi A, Fraser M, ... ... Diamandis EP, et al. Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer. Journal of the National Cancer Institute. 109. PMID 28376164 DOI: 10.1093/jnci/djw258  1
2017 Farkona S, Soosaipillai A, Filippou P, Liaskos C, Bogdanos DP, Diamandis EP, Blasutig IM. Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases. Clinical Chemistry and Laboratory Medicine. PMID 28343172 DOI: 10.1515/cclm-2016-1120  0.64
2017 Korbakis D, Schiza C, Brinc D, Soosaipillai A, Karakosta TD, Légaré C, Sullivan R, Mullen B, Jarvi K, Diamandis EP, Drabovich AP. Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility. Bmc Medicine. 15: 60. PMID 28330469 DOI: 10.1186/s12916-017-0817-5  0.64
2017 Dimitrakopoulos L, Prassas I, Berns EM, Foekens JA, Diamandis EP, Charames GS. Variant peptide detection utilizing mass spectrometry: laying the foundations for proteogenomic identification and validation. Clinical Chemistry and Laboratory Medicine. PMID 28157690 DOI: 10.1515/cclm-2016-0947  1
2017 Filippou P, Korbakis D, Farkona S, Soosaipillai A, Karakosta T, Diamandis EP. A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9. Clinical Proteomics. 14: 4. PMID 28115917 DOI: 10.1186/s12014-017-9140-6  0.64
2017 Yu Y, Prassas I, Muytjens CM, Diamandis EP. Proteomic and peptidomic analysis of human sweat with emphasis on proteolysis. Journal of Proteomics. PMID 28095327 DOI: 10.1016/j.jprot.2017.01.005  1
2017 Clotet S, Soler MJ, Riera M, Pascual J, Fang F, Zhou J, Batruch I, Vasiliou SK, Dimitromanolakis A, Barrios C, Diamandis E, Scholey J, Konvalinka A. SILAC-Based Proteomics of Primary Human Kidney Cells Reveals a Novel Link between Male Sex Hormones and Impaired Energy Metabolism in Diabetic Kidney Disease. Molecular & Cellular Proteomics : McP. PMID 28062795 DOI: 10.1074/mcp.M116.061903  0.92
2016 Kulasingam V, Diamandis EP. Genomic profiling for copy number changes in plasma of ovarian cancer patients - a new era for cancer diagnostics? Bmc Medicine. 14: 186. PMID 27852253 DOI: 10.1186/s12916-016-0741-0  0.56
2016 White-Al Habeeb N, Kulasingam V, Diamandis EP, Yousef GM, Tsongalis GJ, Vermeulen L, Zhu Z, Kamel-Reid S. The Use of Targeted Therapies for Precision Medicine in Oncology. Clinical Chemistry. PMID 27679436 DOI: 10.1373/clinchem.2015.247882  0.76
2016 Muytjens CM, Vasiliou SK, Oikonomopoulou K, Prassas I, Diamandis EP. Putative functions of tissue kallikrein-related peptidases in vaginal fluid. Nature Reviews. Urology. PMID 27603220 DOI: 10.1038/nrurol.2016.161  1
2016 Diamandis EP, Plebani M. Theranos phenomenon - Part 5: Theranos' presentation at the American Association for Clinical Chemistry Annual Conference 2016. Clinical Chemistry and Laboratory Medicine. 54: e313-e314. PMID 27574855 DOI: 10.1515/cclm-2016-0737  1
2016 Vasiliou SK, Diamandis EP, Church GM, Greely HT, Baylis F, Thompson C, Schmitt-Ulms G. CRISPR-Cas9 System: Opportunities and Concerns. Clinical Chemistry. 62: 1304-11. PMID 27551006 DOI: 10.1373/clinchem.2016.263186  0.56
2016 Konvalinka A, Batruch I, Tokar T, Dimitromanolakis A, Reid S, Song X, Pei Y, Drabovich AP, Diamandis EP, Jurisica I, Scholey JW. Quantification of angiotensin II-regulated proteins in urine of patients with polycystic and other chronic kidney diseases by selected reaction monitoring. Clinical Proteomics. 13: 16. PMID 27499720 DOI: 10.1186/s12014-016-9117-x  1
2016 Dragani TA, Castells A, Kulasingam V, Diamandis EP, Earl H, Iams WT, Lovly CM, Sedelaar JP, Schalken JA. Major milestones in translational oncology. Bmc Medicine. 14: 110. PMID 27469586 DOI: 10.1186/s12916-016-0654-y  1
2016 Leung F, Bernardini MQ, Brown MD, Zheng Y, Molina R, Bast RC, Davis G, Serra S, Diamandis EP, Kulasingam V. Validation of a novel biomarker panel for the detection of ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27448593 DOI: 10.1158/1055-9965.EPI-15-1299  1
2016 Di Meo A, Batruch I, Yousef AG, Pasic MD, Diamandis EP, Yousef GM. An integrated proteomic and peptidomic assessment of the normal human urinome. Clinical Chemistry and Laboratory Medicine. PMID 27394047 DOI: 10.1515/cclm-2016-0390  0.92
2016 Karakosta TD, Soosaipillai A, Diamandis EP, Batruch I, Drabovich AP. Quantification of Human Kallikrein-Related Peptidases in Biological Fluids by Multi-Platform Targeted Mass Spectrometry Assays. Molecular & Cellular Proteomics : McP. PMID 27371727 DOI: 10.1074/mcp.M115.057695  1
2016 Oikonomopoulou K, Yu H, Wang Z, Vasiliou SK, Brinc D, Christofi G, Theodorou M, Pavlou P, Hadjisavvas A, Demetriou CA, Kyriacou K, Diamandis EP. Association between Echinococcus granulosus infection and cancer risk - a pilot study in Cyprus. Clinical Chemistry and Laboratory Medicine. PMID 27327131 DOI: 10.1515/cclm-2016-0125  0.56
2016 Leung F, Kulasingam V, Diamandis EP, Hoon DS, Kinzler K, Pantel K, Alix-Panabières C. Circulating Tumor DNA as a Cancer Biomarker: Fact or Fiction? Clinical Chemistry. PMID 27259816 DOI: 10.1373/clinchem.2016.260331  1
2016 Musrap N, Diamandis EP. Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for Antidoping. Clinical Chemistry. PMID 27259815 DOI: 10.1373/clinchem.2016.256198  1
2016 Diamandis EP. Theranos phenomenon - part 4: Theranos at an International Conference. Clinical Chemistry and Laboratory Medicine. PMID 27259230 DOI: 10.1515/cclm-2016-0389  1
2016 Begcevic I, Brinc D, Drabovich AP, Batruch I, Diamandis EP. Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas. Clinical Proteomics. 13: 11. PMID 27186164 DOI: 10.1186/s12014-016-9111-3  0.92
2016 Mangé A, Dimitrakopoulos L, Soosaipillai A, Coopman P, Diamandis EP, Solassol J. An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma. Journal of Proteomics. PMID 27168011 DOI: 10.1016/j.jprot.2016.04.050  1
2016 Farkona S, Diamandis EP, Blasutig IM. Cancer immunotherapy: the beginning of the end of cancer? Bmc Medicine. 14: 73. PMID 27151159 DOI: 10.1186/s12916-016-0623-5  1
2016 Dorn J, Yassouridis A, Walch A, Diamandis EP, Schmitt M, Kiechle M, Wang P, Drecoll E, Schmalfeldt B, Loessner D, Kotzsch M, Magdolen V. Assessment of kallikrein-related peptidase 5 (KLK5) protein expression in tumor tissue of advanced ovarian cancer patients by immunohistochemistry and ELISA: correlation with clinical outcome. American Journal of Cancer Research. 6: 61-70. PMID 27073723  1
2016 Drabovich AP, Pavlou MP, Schiza C, Diamandis EP. Dynamics of protein expression reveals primary targets and secondary messengers of estrogen receptor alpha signaling in MCF-7 breast cancer cells. Molecular & Cellular Proteomics : McP. PMID 27067054 DOI: 10.1074/mcp.M115.057257  1
2016 Li M, Diamandis EP. Theranos phenomenon - part 3. Clinical Chemistry and Laboratory Medicine. 54: e145-6. PMID 26966932 DOI: 10.1515/cclm-2016-0107  1
2016 Diamandis EP. Significant increase of serum prostate-specific antigen after exercise. Clinical Chemistry and Laboratory Medicine. PMID 26910748 DOI: 10.1515/cclm-2016-0018  1
2016 Filippou PS, Karagiannis GS, Musrap N, Diamandis EP. Kallikrein-related peptidases (KLKs) and the hallmarks of cancer. Critical Reviews in Clinical Laboratory Sciences. 1-58. PMID 26886390 DOI: 10.3109/10408363.2016.1154643  1
2016 Diamandis EP. A Word of Caution on New and Revolutionary Diagnostic Tests. Cancer Cell. 29: 141-2. PMID 26859453 DOI: 10.1016/j.ccell.2016.01.003  1
2016 Li M, Diamandis EP. Technology-driven diagnostics: From smart doctor to smartphone. Critical Reviews in Clinical Laboratory Sciences. 1-9. PMID 26857116 DOI: 10.3109/10408363.2016.1149689  1
2016 Dimitrakopoulos L, Prassas I, Diamandis EP, Nesvizhskii A, Kislinger T, Jaffe J, Drabovich A. Proteogenomics: Opportunities and Caveats. Clinical Chemistry. 62: 551-7. PMID 26817480 DOI: 10.1373/clinchem.2015.247858  1
2016 Diamandis EP. Cancer dynamics and the success of cancer screening programs. Clinical Chemistry and Laboratory Medicine. PMID 26751900 DOI: 10.1515/cclm-2015-1201  1
2016 Diamandis EP. A replacement for the testosterone "sex gap". Clinical Chemistry and Laboratory Medicine. 54: e61. PMID 26562040 DOI: 10.1515/cclm-2015-0982  1
2016 Dukic L, Simundic AM, Martinic-Popovic I, Kackov S, Diamandis A, Begcevic I, Diamandis EP. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia. Clinical Biochemistry. 49: 213-8. PMID 26515085 DOI: 10.1016/j.clinbiochem.2015.10.014  1
2016 Diamandis EP, Li M. The side effects of translational omics: overtesting, overdiagnosis, overtreatment. Clinical Chemistry and Laboratory Medicine. 54: 389-96. PMID 26444364 DOI: 10.1515/cclm-2015-0762  1
2016 Diamandis EP, Plebani M. Glypican-1 as a highly sensitive and specific pancreatic cancer biomarker. Clinical Chemistry and Laboratory Medicine. 54: e1-2. PMID 26389634 DOI: 10.1515/cclm-2015-0773  1
2015 Li M, Diamandis EP. Theranos promises a new era of preventive health care - but where's the physician? Clinical Biochemistry. PMID 26436988 DOI: 10.1016/j.clinbiochem.2015.09.005  1
2015 Li M, Diamandis EP. Theranos phenomenon - part 2. Clinical Chemistry and Laboratory Medicine. 53: 1911-2. PMID 26402887 DOI: 10.1515/cclm-2015-0775  1
2015 Knauer MJ, Diamandis EP, Hulot JS, Kim RB, So DY. Clopidogrel and CYP2C19: Pharmacogenetic Testing Ready for Clinical Prime Time? Clinical Chemistry. PMID 26272232 DOI: 10.1373/clinchem.2015.238105  1
2015 Drucker KL, Gianinni C, Decker PA, Diamandis EP, Scarisbrick IA. Prognostic significance of multiple kallikreins in high-grade astrocytoma. Bmc Cancer. 15: 565. PMID 26231762 DOI: 10.1186/s12885-015-1566-5  1
2015 Korbakis D, Dimitromanolakis A, Prassas I, Davis GJ, Barber E, Reckamp KL, Blasutig I, Diamandis EP. Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer. British Journal of Cancer. 113: 484-91. PMID 26180921 DOI: 10.1038/bjc.2015.171  1
2015 Diamandis EP. Getting noticed is half the battle. Science (New York, N.Y.). 349: 206. PMID 26160950 DOI: 10.1126/science.349.6244.206  0.36
2015 Raizman JE, Diamandis EP, Holmes D, Stowasser M, Auchus R, Cavalier E. A Renin-ssance in Primary Aldosteronism Testing: Obstacles and Opportunities for Screening, Diagnosis, and Management. Clinical Chemistry. PMID 26106077 DOI: 10.1373/clinchem.2015.242990  1
2015 Yu Y, Prassas I, Dimitromanolakis A, Diamandis EP. Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics. The Journal of Biological Chemistry. 290: 17762-75. PMID 26032414 DOI: 10.1074/jbc.M115.643551  1
2015 Diamandis EP. Theranos phenomenon: promises and fallacies. Clinical Chemistry and Laboratory Medicine. 53: 989-93. PMID 26030792 DOI: 10.1515/cclm-2015-0356  1
2015 Beriault DR, Diamandis EP, Portelius E, Perret-Liaudet A, Salloway S. Biomarkers, assays, and therapies for Alzheimer disease. Clinical Chemistry. 61: 903-8. PMID 26015517 DOI: 10.1373/clinchem.2015.241901  0.36
2015 Musrap N, Tuccitto A, Karagiannis GS, Saraon P, Batruch I, Diamandis EP. Comparative Proteomics of Ovarian Cancer Aggregate Formation Reveals an Increased Expression of Calcium-activated Chloride Channel Regulator 1 (CLCA1). The Journal of Biological Chemistry. 290: 17218-27. PMID 26004777 DOI: 10.1074/jbc.M115.639773  1
2015 Grober ED, Garbens A, Božović A, Kulasingam V, Fanipour M, Diamandis EP. Accuracy of testosterone concentrations in compounded testosterone products. The Journal of Sexual Medicine. 12: 1381-8. PMID 25963000 DOI: 10.1111/jsm.12898  1
2015 Diamandis EP. A Day in the Life of Dr. Bean and How the NIH Is Wasting $20 Billion per Year. Clinical Chemistry. 61: 783-4. PMID 25922501 DOI: 10.1373/clinchem.2015.239129  1
2015 Duffy MJ, Sturgeon CM, Sölétormos G, Barak V, Molina R, Hayes DF, Diamandis EP, Bossuyt PM. Validation of New Cancer Biomarkers: A Position Statement from the European Group on Tumor Markers. Clinical Chemistry. 61: 809-820. PMID 25882892 DOI: 10.1373/clinchem.2015.239863  0.36
2015 Lennox GK, Eiriksson LR, Reade CJ, Leung F, Mojtahedi G, Atenafu EG, Ferguson SE, Murphy J, Diamandis EP, Kulasingam V, Bernardini MQ. Effectiveness of the risk of malignancy index and the risk of ovarian malignancy algorithm in a cohort of women with ovarian cancer: does histotype and stage matter? International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 25: 809-14. PMID 25855958 DOI: 10.1097/IGC.0000000000000442  0.52
2015 Korbakis D, Brinc D, Schiza C, Soosaipillai A, Jarvi K, Drabovich AP, Diamandis EP. Immunocapture-Selected Reaction Monitoring Screening Facilitates the Development of ELISA for the Measurement of Native TEX101 in Biological Fluids. Molecular & Cellular Proteomics : McP. 14: 1517-26. PMID 25813379 DOI: 10.1074/mcp.M114.047571  1
2015 Diamandis EP. Support staff: Build reward system for ace technicians. Nature. 519: 414. PMID 25810194 DOI: 10.1038/519414e  1
2015 Martínez-Morillo E, Childs C, García BP, Álvarez Menéndez FV, Romaschin AD, Cervellin G, Lippi G, Diamandis EP. Neurofilament medium polypeptide (NFM) protein concentration is increased in CSF and serum samples from patients with brain injury. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. PMID 25720124 DOI: 10.1515/cclm-2014-0908  1
2015 Prassas I, Eissa A, Poda G, Diamandis EP. Unleashing the therapeutic potential of human kallikrein-related serine proteases. Nature Reviews. Drug Discovery. 14: 183-202. PMID 25698643 DOI: 10.1038/nrd4534  1
2015 Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, Berg CD, Cullen J, Diamandis EP, Doria-Rose VP, Goddard KA, Hankinson SE, Kushi LH, Larson EB, McShane LM, et al. Leveraging biospecimen resources for discovery or validation of markers for early cancer detection. Journal of the National Cancer Institute. 107. PMID 25688116 DOI: 10.1093/jnci/djv012  0.52
2015 Cretu D, Liang K, Saraon P, Batruch I, Diamandis EP, Chandran V. Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers. Clinical Proteomics. 12: 1. PMID 25678896 DOI: 10.1186/1559-0275-12-1  1
2015 Abou El Hassan M, Diamandis EP, Karumanchi SA, Shennan AH, Taylor RN. Preeclampsia: an old disease with new tools for better diagnosis and risk management. Clinical Chemistry. 61: 694-8. PMID 25614469 DOI: 10.1373/clinchem.2014.230565  1
2015 Diamandis EP. The Hundred Person Wellness Project and Google's Baseline Study: medical revolution or unnecessary and potentially harmful over-testing? Bmc Medicine. 13: 5. PMID 25575898 DOI: 10.1186/s12916-014-0239-6  1
2015 Rotondo F, Di Ieva A, Kovacs K, Cusimano MD, Syro LV, Diamandis EP, Yousef GM. Human kallikrein 10 in surgically removed human pituitary adenomas. Hormones (Athens, Greece). 14: 272-9. PMID 25553760 DOI: 10.14310/horm.2002.1558  0.52
2015 Florentinus-Mefailoski A, Soosaipillai A, Dufresne J, Diamandis EP, Marshall JG. An enzyme-linked immuno-mass spectrometric assay with the substrate adenosine monophosphate. Analytical and Bioanalytical Chemistry. 407: 1119-30. PMID 25519722 DOI: 10.1007/s00216-014-8323-5  0.64
2015 Di Meo A, Rotondo F, Kovacs K, Cusimano MD, Syro LV, Di Ieva A, Diamandis EP, Yousef GM. Human Kallikrein 10 Expression in Surgically Removed Human Pituitary Corticotroph Adenomas: An Immunohistochemical Study. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 23: 433-7. PMID 25517869 DOI: 10.1097/PAI.0000000000000108  0.76
2015 Korbakis D, Prassas I, Brinc D, Batruch I, Krastins B, Lopez MF, Diamandis EP. Delineating monoclonal antibody specificity by mass spectrometry. Journal of Proteomics. 114: 115-24. PMID 25462431 DOI: 10.1016/j.jprot.2014.11.004  1
2015 Dorn J, Bronger H, Kates R, Slotta-Huspenina J, Schmalfeldt B, Kiechle M, Diamandis EP, Soosaipillai A, Schmitt M, Harbeck N. OVSCORE - a validated score to identify ovarian cancer patients not suitable for primary surgery. Oncology Letters. 9: 418-424. PMID 25436002 DOI: 10.3892/ol.2014.2630  1
2015 Drabovich AP, Martínez-Morillo E, Diamandis EP. Toward an integrated pipeline for protein biomarker development. Biochimica Et Biophysica Acta. 1854: 677-86. PMID 25218201 DOI: 10.1016/j.bbapap.2014.09.006  1
2015 Karagiannis GS, Musrap N, Saraon P, Treacy A, Schaeffer DF, Kirsch R, Riddell RH, Diamandis EP. Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression. Biological Chemistry. 396: 163-83. PMID 25153376 DOI: 10.1515/hsz-2014-0221  1
2015 Diamandis EP. Dr. Lee Goodglick: A valuable collaborator and a dear friend Critical Reviews in Oncogenesis. 20: 335-336. DOI: 10.1615/CritRevOncog.v20.i5-6.50  1
2015 Korbakis D, Dimitromanolakis A, Prassas I, Davis GJ, Barber E, Reckamp KL, Blasutig I, Diamandis EP. Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer British Journal of Cancer. 113: 484-491. DOI: 10.1038/bjc.2015.171  0.52
2014 Saraon P, Drabovich AP, Jarvi KA, Diamandis EP. Mechanisms of Androgen-Independent Prostate Cancer. Ejifcc. 25: 42-54. PMID 27683456  0.92
2014 Schiza CG, Jarv K, Diamandis EP, Drabovich AP. An Emerging Role of TEX101 Protein as a Male Infertility Biomarker. Ejifcc. 25: 9-26. PMID 27683454  0.44
2014 Leung F, Diamandis EP, Kulasingam V. Ovarian cancer biomarkers: current state and future implications from high-throughput technologies. Advances in Clinical Chemistry. 66: 25-77. PMID 25344985 DOI: 10.1016/B978-0-12-801401-1.00002-5  0.56
2014 Teodoro-Morrison T, Diamandis EP, Rifai N, Weetjens BJ, Pennazza G, de Boer NK, Bomers MK. Animal olfactory detection of disease: promises and pitfalls. Clinical Chemistry. 60: 1473-9. PMID 25274554 DOI: 10.1373/clinchem.2014.231282  1
2014 Chan A, Prassas I, Dimitromanolakis A, Brand RE, Serra S, Diamandis EP, Blasutig IM. Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5787-95. PMID 25239611 DOI: 10.1158/1078-0432.CCR-14-0289  0.36
2014 Diamandis EP. Towards identification of true cancer biomarkers. Bmc Medicine. 12: 156. PMID 25220599 DOI: 10.1186/s12916-014-0156-8  1
2014 Walker F, Nicole P, Jallane A, Soosaipillai A, Mosbach V, Oikonomopoulou K, Diamandis EP, Magdolen V, Darmoul D. Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer. Biological Chemistry. 395: 1075-86. PMID 25153388 DOI: 10.1515/hsz-2014-0142  1
2014 Sukumar N, Scott E, Dimitromanolakis A, Misiak A, Prassas I, Diamandis EP, Konvalinka A. Mining for single nucleotide variants (SNVs) at the kallikrein locus with predicted functional consequences. Biological Chemistry. 395: 1037-50. PMID 25153386 DOI: 10.1515/hsz-2014-0136  1
2014 Yousef GM, Pasic M, Diamandis EP. Highlight: the 5th International Symposium on Kallikreins and Kallikrein-Related Peptidases. Biological Chemistry. 395: 913-4. PMID 25153379 DOI: 10.1515/hsz-2014-0228  1
2014 Cretu D, Prassas I, Saraon P, Batruch I, Gandhi R, Diamandis EP, Chandran V. Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry. Clinical Proteomics. 11: 27. PMID 25097465 DOI: 10.1186/1559-0275-11-27  0.52
2014 Smith CR, Batruch I, Bauça JM, Kosanam H, Ridley J, Bernardini MQ, Leung F, Diamandis EP, Kulasingam V. Deciphering the peptidome of urine from ovarian cancer patients and healthy controls. Clinical Proteomics. 11: 23. PMID 24982608 DOI: 10.1186/1559-0275-11-23  0.92
2014 Yu Y, Prassas I, Diamandis EP. Putative kallikrein substrates and their (patho)biological functions. Biological Chemistry. 395: 931-43. PMID 24854536 DOI: 10.1515/hsz-2014-0129  1
2014 Di Meo A, Diamandis EP, Rodriguez H, Hoofnagle AN, Ioannidis J, Lopez M. What is wrong with clinical proteomics? Clinical Chemistry. 60: 1258-66. PMID 24831563 DOI: 10.1373/clinchem.2014.225185  1
2014 Karagiannis GS, Treacy A, Messenger D, Grin A, Kirsch R, Riddell RH, Diamandis EP. Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts. Molecular Oncology. 8: 1240-52. PMID 24812030 DOI: 10.1016/j.molonc.2014.04.004  1
2014 Diamandis EP. Present and future of cancer biomarkers. Clinical Chemistry and Laboratory Medicine. 52: 791-4. PMID 24803613 DOI: 10.1515/cclm-2014-0317  1
2014 Pavlou MP, Dimitromanolakis A, Martinez-Morillo E, Smid M, Foekens JA, Diamandis EP. Integrating meta-analysis of microarray data and targeted proteomics for biomarker identification: application in breast cancer. Journal of Proteome Research. 13: 2897-909. PMID 24799281 DOI: 10.1021/pr500352e  1
2014 Musrap N, Karagiannis GS, Saraon P, Batruch I, Smith C, Diamandis EP. Proteomic analysis of cancer and mesothelial cells reveals an increase in Mucin 5AC during ovarian cancer and peritoneal interaction. Journal of Proteomics. 103: 204-15. PMID 24726482 DOI: 10.1016/j.jprot.2014.03.042  1
2014 Drabovich AP, Saraon P, Jarvi K, Diamandis EP. Seminal plasma as a diagnostic fluid for male reproductive system disorders. Nature Reviews. Urology. 11: 278-88. PMID 24709963 DOI: 10.1038/nrurol.2014.74  1
2014 Lin DC, Diamandis EP, Januzzi JL, Maisel A, Jaffe AS, Clerico A. Natriuretic peptides in heart failure. Clinical Chemistry. 60: 1040-6. PMID 24700774 DOI: 10.1373/clinchem.2014.223057  1
2014 Bery A, Leung F, Smith CR, Diamandis EP, Kulasingam V. Deciphering the ovarian cancer ascites fluid peptidome. Clinical Proteomics. 11: 13. PMID 24694173 DOI: 10.1186/1559-0275-11-13  0.56
2014 Karagiannis GS, Pavlou MP, Saraon P, Musrap N, Xie A, Batruch I, Prassas I, Dimitromanolakis A, Petraki C, Diamandis EP. In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers. Journal of Proteomics. 103: 121-36. PMID 24681409 DOI: 10.1016/j.jprot.2014.03.018  1
2014 Kosanam H, Thai K, Zhang Y, Advani A, Connelly KA, Diamandis EP, Gilbert RE. Diabetes induces lysine acetylation of intermediary metabolism enzymes in the kidney Diabetes. 63: 2432-2439. PMID 24677711 DOI: 10.2337/db12-1770  0.36
2014 Martínez-Morillo E, Hansson O, Atagi Y, Bu G, Minthon L, Diamandis EP, Nielsen HM. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls. Acta Neuropathologica. 127: 633-43. PMID 24633805 DOI: 10.1007/s00401-014-1266-2  1
2014 Oikonomopoulou K, Brinc D, Hadjisavvas A, Christofi G, Kyriacou K, Diamandis EP. The bifacial role of helminths in cancer: involvement of immune and non-immune mechanisms. Critical Reviews in Clinical Laboratory Sciences. 51: 138-48. PMID 24588712 DOI: 10.3109/10408363.2014.886180  1
2014 Diamandis EP. A repository for "rare" tumor markers? Clinical Chemistry and Laboratory Medicine. 52: 795-7. PMID 24516003 DOI: 10.1515/cclm-2014-0012  1
2014 Prassas I, Diamandis EP. Translational researchers beware! Unreliable commercial immunoassays (ELISAs) can jeopardize your research. Clinical Chemistry and Laboratory Medicine. 52: 765-6. PMID 24497227 DOI: 10.1515/cclm-2013-1078  1
2014 Dorn J, Beaufort N, Schmitt M, Diamandis EP, Goettig P, Magdolen V. Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers. Critical Reviews in Clinical Laboratory Sciences. 51: 63-84. PMID 24490956 DOI: 10.3109/10408363.2013.865701  0.36
2014 Diamandis EP. Learning from Siddhartha. Clinical Chemistry. 60: 429. PMID 24474734 DOI: 10.1373/clinchem.2013.215053  1
2014 Martínez-Morillo E, Nielsen HM, Batruch I, Drabovich AP, Begcevic I, Lopez MF, Minthon L, Bu G, Mattsson N, Portelius E, Hansson O, Diamandis EP. Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms. Journal of Proteome Research. 13: 1077-87. PMID 24392642 DOI: 10.1021/pr401060x  1
2014 Saraon P, Trudel D, Kron K, Dmitromanolakis A, Trachtenberg J, Bapat B, van der Kwast T, Jarvi KA, Diamandis EP. Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression. The Prostate. 74: 372-80. PMID 24311408 DOI: 10.1002/pros.22758  1
2014 Martínez-Morillo E, García Hernández P, Begcevic I, Kosanam H, Prieto García B, Alvarez Menéndez FV, Diamandis EP. Identification of novel biomarkers of brain damage in patients with hemorrhagic stroke by integrating bioinformatics and mass spectrometry-based proteomics. Journal of Proteome Research. 13: 969-81. PMID 24295473 DOI: 10.1021/pr401111h  1
2014 Karagiannis GS, Schaeffer DF, Cho CK, Musrap N, Saraon P, Batruch I, Grin A, Mitrovic B, Kirsch R, Riddell RH, Diamandis EP. Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludin. Molecular Oncology. 8: 178-95. PMID 24268521 DOI: 10.1016/j.molonc.2013.10.008  1
2014 Chrystoja CC, Diamandis EP. Whole genome sequencing as a diagnostic test: challenges and opportunities. Clinical Chemistry. 60: 724-33. PMID 24227285 DOI: 10.1373/clinchem.2013.209213  1
2014 Bauça JM, Martínez-Morillo E, Diamandis EP. Peptidomics of urine and other biofluids for cancer diagnostics. Clinical Chemistry. 60: 1052-61. PMID 24212086 DOI: 10.1373/clinchem.2013.211714  1
2014 Rayner K, Dimmeler S, Calin GA, Thum T, Raizman JE, Diamandis EP. Novel biomarkers for acute myocardial infarction: is microRNA the new kid on the block? Clinical Chemistry. 60: 812-7. PMID 24212084 DOI: 10.1373/clinchem.2013.215491  1
2014 Diamandis EP. Tumor microenvironment-released peptides: could they form the basis for an early-diagnosis breast cancer test? Clinical Chemistry. 60: 4-6. PMID 24198244 DOI: 10.1373/clinchem.2013.216143  1
2014 Karagiannis GS, Saraon P, Jarvi KA, Diamandis EP. Proteomic signatures of angiogenesis in androgen-independent prostate cancer. The Prostate. 74: 260-72. PMID 24166580 DOI: 10.1002/pros.22747  1
2014 Prassas I, Brinc D, Farkona S, Leung F, Dimitromanolakis A, Chrystoja CC, Brand R, Kulasingam V, Blasutig IM, Diamandis EP. False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125. Clinical Chemistry. 60: 381-8. PMID 24097894 DOI: 10.1373/clinchem.2013.215236  1
2014 Oikonomopoulou K, Hansen KK, Chapman K, Vergnolle N, Diamandis EP, Hollenberg MD. Kallikrein-mediated activation of PARs in inflammation and nociception Inflammation Research. 56: S499-S502. DOI: 10.1007/BF03353889  0.36
2013 Schmitt M, Magdolen V, Yang F, Kiechle M, Bayani J, Yousef GM, Scorilas A, Diamandis EP, Dorn J. Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies. Radiology and Oncology. 47: 319-29. PMID 24294176 DOI: 10.2478/raon-2013-0053  1
2013 Niederkofler EE, Phillips DA, Krastins B, Kulasingam V, Kiernan UA, Tubbs KA, Peterman SM, Prakash A, Diamandis EP, Lopez MF, Nedelkov D. Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1. Plos One. 8: e81125. PMID 24278387 DOI: 10.1371/journal.pone.0081125  1
2013 Drabovich AP, Dimitromanolakis A, Saraon P, Soosaipillai A, Batruch I, Mullen B, Jarvi K, Diamandis EP. Differential diagnosis of azoospermia with proteomic biomarkers ECM1 and TEX101 quantified in seminal plasma. Science Translational Medicine. 5: 212ra160. PMID 24259048 DOI: 10.1126/scitranslmed.3006260  1
2013 Oikonomopoulou K, DeAngelis RA, Chen H, Diamandis EP, Hollenberg MD, Ricklin D, Lambris JD. Induction of complement C3a receptor responses by kallikrein-related peptidase 14. Journal of Immunology (Baltimore, Md. : 1950). 191: 3858-66. PMID 24014879 DOI: 10.4049/jimmunol.1202999  1
2013 Makawita S, Dimitromanolakis A, Soosaipillai A, Soleas I, Chan A, Gallinger S, Haun RS, Blasutig IM, Diamandis EP. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9. Bmc Cancer. 13: 404. PMID 24007603 DOI: 10.1186/1471-2407-13-404  1
2013 Stephan C, Diamandis EP, Kristiansen G. Research forever - Klaus Jung. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 51: e221. PMID 23950575 DOI: 10.1515/cclm-2013-0582  1
2013 Diamandis EP. More discussion on journal impact factor. Clinical Chemistry and Laboratory Medicine. 51: 2271. PMID 23907426 DOI: 10.1515/cclm-2013-0515  1
2013 Konvalinka A, Zhou J, Dimitromanolakis A, Drabovich AP, Fang F, Gurley S, Coffman T, John R, Zhang SL, Diamandis EP, Scholey JW. Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC). The Journal of Biological Chemistry. 288: 24834-47. PMID 23846697 DOI: 10.1074/jbc.M113.485326  1
2013 Kosanam H, Prassas I, Chrystoja CC, Soleas I, Chan A, Dimitromanolakis A, Blasutig IM, Rückert F, Gruetzmann R, Pilarsky C, Maekawa M, Brand R, Diamandis EP. Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues. Molecular & Cellular Proteomics : McP. 12: 2820-32. PMID 23798558 DOI: 10.1074/mcp.M112.023507  1
2013 Dorn J, Bayani J, Yousef GM, Yang F, Magdolen V, Kiechle M, Diamandis EP, Schmitt M. Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies. Thrombosis and Haemostasis. 110: 408-22. PMID 23765253 DOI: 10.1160/TH13-03-0206  1
2013 Cretu D, Diamandis EP, Chandran V. Delineating the synovial fluid proteome: recent advancements and ongoing challenges in biomarker research. Critical Reviews in Clinical Laboratory Sciences. 50: 51-63. PMID 23758541 DOI: 10.3109/10408363.2013.802408  1
2013 Diamandis EP. Nobelitis: a common disease among Nobel laureates? Clinical Chemistry and Laboratory Medicine. 51: 1573-4. PMID 23729580 DOI: 10.1515/cclm-2013-0273  1
2013 Bailey D, Diamandis EP, Greub G, Poutanen SM, Christensen JJ, Kostrzew M. Use of MALDI-TOF for diagnosis of microbial infections. Clinical Chemistry. 59: 1435-41. PMID 23695295 DOI: 10.1373/clinchem.2013.204644  0.52
2013 Karagiannis GS, Berk A, Dimitromanolakis A, Diamandis EP. Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1. Molecular Oncology. 7: 826-39. PMID 23659962 DOI: 10.1016/j.molonc.2013.04.002  1
2013 Begcevic I, Kosanam H, Martínez-Morillo E, Dimitromanolakis A, Diamandis P, Kuzmanov U, Hazrati LN, Diamandis EP. Semiquantitative proteomic analysis of human hippocampal tissues from Alzheimer's disease and age-matched control brains. Clinical Proteomics. 10: 5. PMID 23635041 DOI: 10.1186/1559-0275-10-5  1
2013 Childs C, Martínez-Morillo E, Wai AP, Zu MM, Diamandis A, Diamandis EP. Exploring the relationship between serum biomarkers, acute intracerebral changes and outcome after severe traumatic brain injury (TBI). Clinical Chemistry and Laboratory Medicine. 51: e195-7. PMID 23612666 DOI: 10.1515/cclm-2013-0216  1
2013 Oikonomopoulou K, Brinc D, Kyriacou K, Diamandis EP. Infection and cancer: revaluation of the hygiene hypothesis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2834-41. PMID 23536438 DOI: 10.1158/1078-0432.CCR-12-3661  1
2013 Leung F, Dimitromanolakis A, Kobayashi H, Diamandis EP, Kulasingam V. Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients Clinical Biochemistry. 46: 1462-1468. PMID 23528302 DOI: 10.1016/j.clinbiochem.2013.03.010  0.72
2013 Pasic MD, Yousef GM, Diamandis EP. The proteomic revolution in laboratory medicine. Clinical Biochemistry. 46: 397-8. PMID 23497914 DOI: 10.1016/j.clinbiochem.2013.02.012  1
2013 Saraon P, Cretu D, Musrap N, Karagiannis GS, Batruch I, Drabovich AP, van der Kwast T, Mizokami A, Morrissey C, Jarvi K, Diamandis EP. Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression. Molecular & Cellular Proteomics : McP. 12: 1589-601. PMID 23443136 DOI: 10.1074/mcp.M112.023887  1
2013 Kulasingam V, Diamandis EP. Fascin-1 is a novel biomarker of aggressiveness in some carcinomas. Bmc Medicine. 11: 53. PMID 23443037 DOI: 10.1186/1741-7015-11-53  1
2013 Shea JL, Diamandis EP, Hoffman B, Lo YM, Canick J, van den Boom D. A new era in prenatal diagnosis: the use of cell-free fetal DNA in maternal circulation for detection of chromosomal aneuploidies. Clinical Chemistry. 59: 1151-9. PMID 23426426 DOI: 10.1373/clinchem.2012.201996  1
2013 Cho CK, Drabovich AP, Karagiannis GS, Martínez-Morillo E, Dason S, Dimitromanolakis A, Diamandis EP. Quantitative proteomic analysis of amniocytes reveals potentially dysregulated molecular networks in Down syndrome. Clinical Proteomics. 10: 2. PMID 23394617 DOI: 10.1186/1559-0275-10-2  1
2013 Kuzmanov U, Kosanam H, Diamandis EP. The sweet and sour of serological glycoprotein tumor biomarker quantification. Bmc Medicine. 11: 31. PMID 23390961 DOI: 10.1186/1741-7015-11-31  1
2013 Pavlou MP, Dimitromanolakis A, Diamandis EP. Coupling proteomics and transcriptomics in the quest of subtype-specific proteins in breast cancer. Proteomics. 13: 1083-95. PMID 23386393 DOI: 10.1002/pmic.201200526  1
2013 Kuzmanov U, Musrap N, Kosanam H, Smith CR, Batruch I, Dimitromanolakis A, Diamandis EP. Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluids. Clinical Chemistry and Laboratory Medicine. 51: 1467-76. PMID 23241603 DOI: 10.1515/cclm-2012-0642  1
2013 Eisenhofer G, Pacak K, Maher ER, Young WF, de Krijger RR. Pheochromocytoma. Clinical Chemistry. 59: 466-72. PMID 23209036 DOI: 10.1373/clinchem.2012.182246  1
2013 Diamandis EP, Bast RC, Lopez-Otín C. Conquering cancer in our lifetime: new diagnostic and therapeutic trends. Clinical Chemistry. 59: 1-3. PMID 23204223 DOI: 10.1373/clinchem.2012.186940  1
2013 Diamandis EP, Bast RC, Gold P, Chu TM, Magnani JL. Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9. Clinical Chemistry. 59: 22-31. PMID 23204222 DOI: 10.1373/clinchem.2012.187047  1
2013 Chrystoja CC, Diamandis EP, Brand R, Rückert F, Haun R, Molina R. Pancreatic cancer. Clinical Chemistry. 59: 41-6. PMID 23136253 DOI: 10.1373/clinchem.2012.196642  1
2013 Bayani J, Kuzmanov U, Saraon P, Fung WA, Soosaipillai A, Squire JA, Diamandis EP. Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression. Clinical Chemistry. 59: 296-305. PMID 23136250 DOI: 10.1373/clinchem.2012.193060  0.52
2013 Estey MP, Diamandis EP, Van Der Straeten C, Tower SS, Hart AJ, Moyer TP. Cobalt and chromium measurement in patients with metal hip prostheses. Clinical Chemistry. 59: 880-6. PMID 23115056 DOI: 10.1373/clinchem.2012.193037  1
2013 Eissa A, Cretu D, Soosaipillai A, Thavaneswaran A, Pellett F, Diamandis A, Cevikbas F, Steinhoff M, Diamandis EP, Gladman D, Chandran V. Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease. Clinical Chemistry and Laboratory Medicine. 51: 317-25. PMID 23096109 DOI: 10.1515/cclm-2012-0251  1
2013 Sölétormos G, Duffy MJ, Hayes DF, Sturgeon CM, Barak V, Bossuyt PM, Diamandis EP, Gion M, Hyltoft-Petersen P, Lamerz RM, Nielsen DL, Sibley P, Tholander B, Tuxen MK, Bonfrer JM. Design of tumor biomarker-monitoring trials: a proposal by the European Group on Tumor Markers. Clinical Chemistry. 59: 52-9. PMID 23034139 DOI: 10.1373/clinchem.2011.180778  1
2013 Chan A, Diamandis EP, Blasutig IM. Strategies for discovering novel pancreatic cancer biomarkers. Journal of Proteomics. 81: 126-34. PMID 23026552 DOI: 10.1016/j.jprot.2012.09.025  1
2013 Pavlou MP, Diamandis EP, Blasutig IM. The long journey of cancer biomarkers from the bench to the clinic. Clinical Chemistry. 59: 147-57. PMID 23019307 DOI: 10.1373/clinchem.2012.184614  0.36
2013 Konforte D, Diamandis EP. Is early detection of cancer with circulating biomarkers feasible? Clinical Chemistry. 59: 35-7. PMID 22522223 DOI: 10.1373/clinchem.2012.184903  1
2013 Leung F, Musrap N, Diamandis EP, Kulasingam V. Advances in mass spectrometry-based technologies to direct personalized medicine in ovarian cancer Translational Proteomics. 1: 74-86. DOI: 10.1016/j.trprot.2013.08.001  1
2013 Drabovich AP, Pavlou MP, Batruch I, Diamandis EP. Proteomic and Mass Spectrometry Technologies for Biomarker Discovery Proteomic and Metabolomic Approaches to Biomarker Discovery. 17-37. DOI: 10.1016/B978-0-12-394446-7.00002-9  1
2013 Pavlou MP, Diamandis EP. Validation of Candidate Protein Biomarkers Genomic and Personalized Medicine. 1: 263-271. DOI: 10.1016/B978-0-12-382227-7.00022-7  0.72
2013 Eissa A, Diamandis EP. Kallikrein-related Peptidase 14 Handbook of Proteolytic Enzymes. 3: 2809-2813. DOI: 10.1016/B978-0-12-382219-2.00618-9  1
2013 Cretu D, Diamandis EP. Kallikrein-related Peptidase 13 Handbook of Proteolytic Enzymes. 3: 2805-2808. DOI: 10.1016/B978-0-12-382219-2.00617-7  1
2013 Luo LY, Diamandis EP. Human Tissue Kallikrein 10 Handbook of Proteolytic Enzymes. 3: 2798-2801. DOI: 10.1016/B978-0-12-382219-2.00615-3  1
2013 Eissa A, Diamandis EP. Kallikrein-Related Peptidase 8 Handbook of Proteolytic Enzymes. 3: 2792-2798. DOI: 10.1016/B978-0-12-382219-2.00614-1  1
2012 Darling MR, Hashem NN, Zhang I, Mohamed AB, Fung K, Kwan K, Mara TW, Daley TD, Diamandis EP. Kallikrein-related peptidase 10 expression in salivary gland tissues and tumours. The International Journal of Biological Markers. 27: e381-8. PMID 23250777 DOI: 10.5301/JBM.2012.10373  1
2012 Leung F, Diamandis EP, Kulasingam V. From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade. Biomarkers in Medicine. 6: 613-25. PMID 23075239 DOI: 10.2217/bmm.12.70  1
2012 Sardana G, Diamandis EP. Biomarkers for the diagnosis of new and recurrent prostate cancer. Biomarkers in Medicine. 6: 587-96. PMID 23075237 DOI: 10.2217/bmm.12.72  1
2012 Martínez-Morillo E, Diamandis A, Romaschin AD, Diamandis EP. Kallikrein 6 as a serum prognostic marker in patients with aneurysmal subarachnoid hemorrhage. Plos One. 7: e45676. PMID 23049835 DOI: 10.1371/journal.pone.0045676  1
2012 Karagiannis GS, Poutahidis T, Erdman SE, Kirsch R, Riddell RH, Diamandis EP. Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Molecular Cancer Research : McR. 10: 1403-18. PMID 23024188 DOI: 10.1158/1541-7786.MCR-12-0307  1
2012 Leung F, Soosaipillai A, Kulasingam V, Diamandis EP. CUB and zona pellucida-like domain-containing protein 1 (CUZD1): A novel serological biomarker for ovarian cancer Clinical Biochemistry. 45: 1543-1546. PMID 22985796 DOI: 10.1016/j.clinbiochem.2012.08.011  1
2012 Saraon P, Musrap N, Cretu D, Karagiannis GS, Batruch I, Smith C, Drabovich AP, Trudel D, van der Kwast T, Morrissey C, Jarvi KA, Diamandis EP. Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer. The Journal of Biological Chemistry. 287: 34019-31. PMID 22908226 DOI: 10.1074/jbc.M112.384438  1
2012 Diamandis EP. Biomarker validation is still the bottleneck in biomarker research Journal of Internal Medicine. 272: 620-620. PMID 22905877 DOI: 10.1111/j.1365-2796.2012.02579.x  1
2012 Musrap N, Diamandis EP. Revisiting the complexity of the ovarian cancer microenvironment--clinical implications for treatment strategies. Molecular Cancer Research : McR. 10: 1254-64. PMID 22896662 DOI: 10.1158/1541-7786.MCR-12-0353  1
2012 Diamandis EP. The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem? Bmc Medicine. 10: 87. PMID 22876833 DOI: 10.1186/1741-7015-10-87  1
2012 Olkhov-Mitsel E, Van der Kwast T, Kron KJ, Ozcelik H, Briollais L, Massey C, Recker F, Kwiatkowski M, Fleshner NE, Diamandis EP, Zlotta AR, Bapat B. Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer. Epigenetics : Official Journal of the Dna Methylation Society. 7: 1037-45. PMID 22874102 DOI: 10.4161/epi.21524  1
2012 Konforte D, Diamandis EP, van Venrooij WJ, Lories R, Ward MM. Autoimmune diseases: early diagnosis and new treatment strategies. Clinical Chemistry. 58: 1510-4. PMID 22761474 DOI: 10.1373/clinchem.2012.189480  1
2012 Martínez-Morillo E, Cho CK, Drabovich AP, Shaw JL, Soosaipillai A, Diamandis EP. Development of a multiplex selected reaction monitoring assay for quantification of biochemical markers of down syndrome in amniotic fluid samples. Journal of Proteome Research. 11: 3880-7. PMID 22681384 DOI: 10.1021/pr300355a  1
2012 Prakash A, Rezai T, Krastins B, Sarracino D, Athanas M, Russo P, Zhang H, Tian Y, Li Y, Kulasingam V, Drabovich A, Smith CR, Batruch I, Oran PE, Fredolini C, ... ... Diamandis EP, et al. Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies. Journal of Proteome Research. 11: 3986-95. PMID 22639787 DOI: 10.1021/pr300014s  1
2012 Martínez-Morillo E, Diamandis A, Diamandis EP. Reference intervals and biological variation for kallikrein 6: influence of age and renal failure. Clinical Chemistry and Laboratory Medicine. 50: 931-4. PMID 22628337 DOI: 10.1515/cclm-2012-0075  1
2012 Kuzmanov U, Smith CR, Batruch I, Soosaipillai A, Diamandis A, Diamandis EP. Separation of kallikrein 6 glycoprotein subpopulations in biological fluids by anion-exchange chromatography coupled to ELISA and identification by mass spectrometry. Proteomics. 12: 799-809. PMID 22539431 DOI: 10.1002/pmic.201100371  1
2012 Drabovich AP, Pavlou MP, Dimitromanolakis A, Diamandis EP. Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assay. Molecular & Cellular Proteomics : McP. 11: 422-34. PMID 22535206 DOI: 10.1074/mcp.M111.015214  1
2012 Prassas I, Chrystoja CC, Makawita S, Diamandis EP. Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery. Bmc Medicine. 10: 39. PMID 22515324 DOI: 10.1186/1741-7015-10-39  1
2012 Chung H, Hamza M, Oikonomopoulou K, Gratio V, Saifeddine M, Virca GD, Diamandis EP, Hollenberg MD, Darmoul D. Kallikrein-related peptidase signaling in colon carcinoma cells: targeting proteinase-activated receptors. Biological Chemistry. 393: 413-20. PMID 22505523 DOI: 10.1515/bc-2011-231  1
2012 Seiz L, Dorn J, Kotzsch M, Walch A, Grebenchtchikov NI, Gkazepis A, Schmalfeldt B, Kiechle M, Bayani J, Diamandis EP, Langer R, Sweep FCGJ, Schmitt M, Magdolen V. Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients Biological Chemistry. 393: 391-401. PMID 22505521 DOI: 10.1515/hsz-2011-0264  1
2012 Petraki C, Youssef YM, Dubinski W, Lichner Z, Scorilas A, Pasic MD, Komborozos V, Khalil B, Streutker C, Diamandis EP, Yousef GM. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 33: 1209-14. PMID 22437349 DOI: 10.1007/s13277-012-0368-5  1
2012 Karagiannis GS, Petraki C, Prassas I, Saraon P, Musrap N, Dimitromanolakis A, Diamandis EP. Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis. Oncotarget. 3: 267-85. PMID 22408128 DOI: 10.18632/oncotarget.451  1
2012 Diamandis EP. EPCA-2: A highly specific serum marker for prostate cancer Clinical Biochemistry. 45: 600. PMID 22405900 DOI: 10.1016/j.clinbiochem.2012.02.019  1
2012 Shaw JLV, Diamandis EP, Horne AW, Barnhart K, Bourne T, Messinis IE. Ectopic pregnancy Clinical Chemistry. 58: 1278-1285. PMID 22389311 DOI: 10.1373/clinchem.2012.184168  1
2012 McDermed JE, Sanders R, Fait S, Klem RE, Sarno MJ, Adams TH, Diamandis EP. Nucleic acid detection immunoassay for prostate-specific antigen based on immuno-PCR methodology. Clinical Chemistry. 58: 732-40. PMID 22361936 DOI: 10.1373/clinchem.2011.170290  1
2012 Shea J, Diamandis EP, Sharma AM, Després JP, Ezzat S, Greenway F. The obesity epidemic Clinical Chemistry. 58: 968-973. PMID 22311921 DOI: 10.1373/clinchem.2011.180976  1
2012 Kagedan D, Lecker I, Batruch I, Smith C, Kaploun I, Lo K, Grober E, Diamandis EP, Jarvi KA. Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometry. Clinical Proteomics. 9: 2. PMID 22309592 DOI: 10.1186/1559-0275-9-2  1
2012 Petraki C, Dubinski W, Scorilas A, Saleh C, Pasic MD, Komborozos V, Khalil B, Gabril MY, Streutker C, Diamandis EP, Yousef GM. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer. Pathology, Research and Practice. 208: 104-8. PMID 22285222 DOI: 10.1016/j.prp.2011.12.010  1
2012 Rifai N, Diamandis EP, Lo YM, Kricka LJ, Wilding P, Ladenson JH, Wittwer CT. Advancing laboratory medicine through innovation: a tale of six inventors. Clinical Chemistry. 58: 502-10. PMID 22238255 DOI: 10.1373/clinchem.2011.178582  1
2012 Kosanam H, Sato M, Batruch I, Smith C, Keshavjee S, Liu M, Diamandis EP. Differential proteomic analysis of bronchoalveolar lavage fluid from lung transplant patients with and without chronic graft dysfunction. Clinical Biochemistry. 45: 223-30. PMID 22206736 DOI: 10.1016/j.clinbiochem.2011.11.015  1
2012 Batruch I, Smith CR, Mullen BJ, Grober E, Lo KC, Diamandis EP, Jarvi KA. Analysis of seminal plasma from patients with non-obstructive azoospermia and identification of candidate biomarkers of male infertility. Journal of Proteome Research. 11: 1503-11. PMID 22188163 DOI: 10.1021/pr200812p  1
2012 Florentinus AK, Bowden P, Sardana G, Diamandis EP, Marshall JG. Identification and quantification of peptides and proteins secreted from prostate epithelial cells by unbiased liquid chromatography tandem mass spectrometry using goodness of fit and analysis of variance. Journal of Proteomics. 75: 1303-17. PMID 22120120 DOI: 10.1016/j.jprot.2011.11.002  1
2012 Bayani J, Diamandis EP. The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6) Clinical Chemistry and Laboratory Medicine. 50: 211-233. PMID 22047144 DOI: 10.1515/cclm.2011.750  1
2012 Konvalinka A, Scholey JW, Diamandis EP. Searching for new biomarkers of renal diseases through proteomics Clinical Chemistry. 58: 353-365. PMID 21980170 DOI: 10.1373/clinchem.2011.165969  1
2012 Rückert F, Aust D, Böhme I, Werner K, Brandt A, Diamandis EP, Krautz C, Hering S, Saeger HD, Grützmann R, Pilarsky C. Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method. The Journal of Surgical Research. 172: 29-39. PMID 21683373 DOI: 10.1016/j.jss.2011.04.021  1
2011 Saraon P, Jarvi K, Diamandis EP. Molecular alterations during progression of prostate cancer to androgen independence. Clinical Chemistry. 57: 1366-75. PMID 21956922 DOI: 10.1373/clinchem.2011.165977  1
2011 Drabovich AP, Jarvi K, Diamandis EP. Verification of male infertility biomarkers in seminal plasma by multiplex selected reaction monitoring assay Molecular &Amp; Cellular Proteomics : McP. 10. PMID 21933954 DOI: 10.1074/mcp.M110.004127  1
2011 Kosanam H, Makawita S, Judd B, Newman A, Diamandis EP. Mining the malignant ascites proteome for pancreatic cancer biomarkers. Proteomics. 11: 4551-8. PMID 21932441 DOI: 10.1002/pmic.201100264  0.52
2011 Gratio V, Loriot C, Virca GD, Oikonomopoulou K, Walker F, Diamandis EP, Hollenberg MD, Darmoul D. Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells. The American Journal of Pathology. 179: 2625-36. PMID 21907696 DOI: 10.1016/j.ajpath.2011.07.016  1
2011 Prassas I, Karagiannis GS, Batruch I, Dimitromanolakis A, Datti A, Diamandis EP. Digitoxin-induced cytotoxicity in cancer cells is mediated through distinct kinase and interferon signaling networks. Molecular Cancer Therapeutics. 10: 2083-93. PMID 21859838 DOI: 10.1158/1535-7163.MCT-11-0421  1
2011 Nam RK, Kattan MW, Chin JL, Trachtenberg J, Singal R, Rendon R, Klotz LH, Sugar L, Sherman C, Izawa J, Bell D, Stanimirovic A, Venkateswaran V, Diamandis EP, Yu C, et al. Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2959-64. PMID 21690464 DOI: 10.1200/JCO.2010.32.6371  0.52
2011 Pavlou M, Diamandis EP. I detected my cancer with my smart phone Clinical Chemistry. 57: 1221-1223. PMID 21690203 DOI: 10.1373/clinchem.2011.165761  1
2011 Makawita S, Smith C, Batruch I, Zheng Y, Rückert F, Grützmann R, Pilarsky C, Gallinger S, Diamandis EP. Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Molecular & Cellular Proteomics : McP. 10: M111.008599. PMID 21653254 DOI: 10.1074/mcp.M111.008599  1
2011 Guillon-Munos A, Oikonomopoulou K, Michel N, Smith CR, Petit-Courty A, Canepa S, Reverdiau P, Heuzè-Vourc'h N, Diamandis EP, Courty Y. Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors Journal of Biological Chemistry. 286: 25505-25518. PMID 21628462 DOI: 10.1074/jbc.M110.213231  1
2011 Cho CK, Drabovich AP, Batruch I, Diamandis EP. Verification of a biomarker discovery approach for detection of Down syndrome in amniotic fluid via multiplex selected reaction monitoring (SRM) assay. Journal of Proteomics. 74: 2052-9. PMID 21624510 DOI: 10.1016/j.jprot.2011.05.025  1
2011 Diamandis EP, Pantel K, Scher HI, Terstappen L, Lianidou E. Circulating cancer cells and their clinical applications. Clinical Chemistry. 57: 1478-84. PMID 21586640 DOI: 10.1373/clinchem.2011.166678  1
2011 Kulasingam V, Smith CR, Batruch I, Diamandis EP. Immuno-mass spectrometry: Quantification of low-abundance proteins in biological fluids Methods in Molecular Biology. 728: 207-218. PMID 21468950 DOI: 10.1007/978-1-61779-068-3_13  1
2011 Pasic MD, Diamandis EP, McLaurin J, Holtzman DM, Schmitt-Ulms G, Quirion R. Alzheimer disease: advances in pathogenesis, diagnosis, and therapy. Clinical Chemistry. 57: 664-9. PMID 21310870 DOI: 10.1373/clinchem.2011.161828  1
2011 Dorn J, Magdolen V, Gkazepis A, Gerte T, Harlozinska A, Sedlaczek P, Diamandis EP, Schuster T, Harbeck N, Kiechle M, Schmitt M. Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients' survival Annals of Oncology. 22: 1783-1790. PMID 21273346 DOI: 10.1093/annonc/mdq701  1
2011 Diamandis EP, Goodglick L, Planque C, Thornquist MD. Pentraxin-3 is a novel biomarker of lung carcinoma Clinical Cancer Research. 17: 2395-2399. PMID 21257721 DOI: 10.1158/1078-0432.CCR-10-3024  1
2011 Batruch I, Lecker I, Kagedan D, Smith CR, Mullen BJ, Grober E, Lo KC, Diamandis EP, Jarvi KA. Proteomic analysis of seminal plasma from normal volunteers and post-vasectomy patients identifies over 2000 proteins and candidate biomarkers of the urogenital system. Journal of Proteome Research. 10: 941-53. PMID 21142078 DOI: 10.1021/pr100745u  1
2011 Eissa A, Amodeo V, Smith CR, Diamandis EP. Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade. The Journal of Biological Chemistry. 286: 687-706. PMID 20940292 DOI: 10.1074/jbc.M110.125310  0.84
2010 Karagiannis GS, Pavlou MP, Diamandis EP. Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology. Molecular Oncology. 4: 496-510. PMID 20934395 DOI: 10.1016/j.molonc.2010.09.001  1
2010 White NM, Bui A, Mejia-Guerrero S, Chao J, Soosaipillai A, Youssef Y, Mankaruos M, Honey RJ, Stewart R, Pace KT, Sugar L, Diamandis EP, Doré J, Yousef GM. Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs. Biological Chemistry. 391: 411-23. PMID 20180642 DOI: 10.1515/BC.2010.041  1
2009 Yousef GM, Diamandis EP. The human kallikrein gene family: new biomarkers for ovarian cancer. Cancer Treatment and Research. 149: 165-87. PMID 19763436 DOI: 10.1007/978-0-387-98094-2_8  1
2008 Prassas I, Diamandis EP. Novel therapeutic applications of cardiac glycosides. Nature Reviews. Drug Discovery. 7: 926-35. PMID 18948999 DOI: 10.1038/nrd2682  1
2008 Prassas I, Paliouras M, Datti A, Diamandis EP. High-throughput screening identifies cardiac glycosides as potent inhibitors of human tissue kallikrein expression: implications for cancer therapies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 5778-84. PMID 18794087 DOI: 10.1158/1078-0432.CCR-08-0706  1
2008 Eissa A, Diamandis EP. Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions. Biological Chemistry. 389: 669-80. PMID 18627299 DOI: 10.1515/BC.2008.079  0.84
2008 Chow TF, Crow M, Earle T, El-Said H, Diamandis EP, Yousef GM. Kallikreins as microRNA targets: an in silico and experimental-based analysis. Biological Chemistry. 389: 731-8. PMID 18627289 DOI: 10.1515/BC.2008.071  1
2007 Yousef GM, Denic N, Wadhwa J, Chandracanth SA, Smith T, Elms F, Diamandis EP. Intravagal ectopic parathyroid presenting as vocal cord paralysis: case report and review of the literature. The Journal of Otolaryngology. 36: E93-5. PMID 18076837  0.52
2006 Lundwall A, Band V, Blaber M, Clements JA, Courty Y, Diamandis EP, Fritz H, Lilja H, Malm J, Maltais LJ, Olsson AY, Petraki C, Scorilas A, Sotiropoulou G, Stenman UH, et al. A comprehensive nomenclature for serine proteases with homology to tissue kallikreins. Biological Chemistry. 387: 637-41. PMID 16800724 DOI: 10.1515/BC.2006.082  0.76
2006 Stephan C, Jung K, Nakamura T, Yousef GM, Kristiansen G, Diamandis EP. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer. International Journal of Urology : Official Journal of the Japanese Urological Association. 13: 238-43. PMID 16643616 DOI: 10.1111/j.1442-2042.2006.01276.x  1
2006 Petraki CD, Gregorakis AK, Vaslamatzis MM, Papanastasiou PA, Yousef GM, Levesque MA, Diamandis EP. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 27: 1-7. PMID 16340244 DOI: 10.1159/000090150  1
2005 Yousef GM, Ejeckam GC, Best LM, Diamandis EP. Collecting duct carcinoma associated with oncocytoma. International Braz J Urol : Official Journal of the Brazilian Society of Urology. 31: 465-7; discussion 46. PMID 16255793  1
2005 Stephan C, Jung K, Soosaipillai A, Yousef GM, Cammann H, Meyer H, Xu C, Diamandis EP. Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detection. Bju International. 96: 521-7. PMID 16104903 DOI: 10.1111/j.1464-410X.2005.05677.x  1
2005 Yousef GM, White NM, Michael IP, Cho JC, Robb JD, Kurlender L, Khan S, Diamandis EP. Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 26: 227-35. PMID 16103744 DOI: 10.1159/000087377  1
2005 Yousef GM, Obiezu CV, Luo LY, Magklara A, Borgoño CA, Kishi T, Memari N, Michael lP, Sidiropoulos M, Kurlender L, Economopolou K, Kapadia C, Komatsu N, Petraki C, Elliott M, ... ... Diamandis EP, et al. Human tissue kallikreins: from gene structure to function and clinical applications. Advances in Clinical Chemistry. 39: 11-79. PMID 16013667 DOI: 10.1016/S0065-2423(04)39002-5  1
2005 Kurlender L, Borgono C, Michael IP, Obiezu C, Elliott MB, Yousef GM, Diamandis EP. A survey of alternative transcripts of human tissue kallikrein genes. Biochimica Et Biophysica Acta. 1755: 1-14. PMID 15878240 DOI: 10.1016/j.bbcan.2005.02.001  1
2005 Michael IP, Kurlender L, Memari N, Yousef GM, Du D, Grass L, Stephan C, Jung K, Diamandis EP. Intron retention: a common splicing event within the human kallikrein gene family. Clinical Chemistry. 51: 506-15. PMID 15650036 DOI: 10.1373/clinchem.2004.042341  1
2004 Yousef GM, Borgoño CA, White NM, Robb JD, Michael IP, Oikonomopoulou K, Khan S, Diamandis EP. In silico analysis of the human kallikrein gene 6. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 25: 282-9. PMID 15627893 DOI: 10.1159/000081393  1
2004 Yousef GM, White NM, Kurlender L, Michael I, Memari N, Robb JD, Katsaros D, Stephan C, Jung K, Diamandis EP. The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 25: 221-7. PMID 15627884 DOI: 10.1159/000081384  1
2004 Yousef GM, Borgono CA, Michael IP, Diamandis EP. Cloning of a kallikrein pseudogene. Clinical Biochemistry. 37: 961-7. PMID 15498522 DOI: 10.1016/j.clinbiochem.2004.07.012  1
2004 Kurlender L, Yousef GM, Memari N, Robb JD, Michael IP, Borgoño C, Katsaros D, Stephan C, Jung K, Diamandis EP. Differential expression of a human kallikrein 5 (KLK5) splice variant in ovarian and prostate cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 25: 149-56. PMID 15361712 DOI: 10.1159/000079147  1
2004 Yousef GM, Borgoño CA, Michael IP, Davidian C, Stephan C, Jung K, Diamandis EP. Molecular cloning of a new gene which is differentially expressed in breast and prostate cancers. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 25: 122-33. PMID 15361709 DOI: 10.1159/000079144  1
2004 Yousef GM, Elliott MB, Kopolovic AD, Serry E, Diamandis EP. Sequence and evolutionary analysis of the human trypsin subfamily of serine peptidases. Biochimica Et Biophysica Acta. 1698: 77-86. PMID 15063317 DOI: 10.1016/j.bbapap.2003.10.008  1
2004 Yousef GM, Borgoño CA, Popalis C, Yacoub GM, Polymeris ME, Soosaipillai A, Diamandis EP. In-silico analysis of kallikrein gene expression in pancreatic and colon cancers. Anticancer Research. 24: 43-51. PMID 15015574  1
2004 Diamandis EP, Yousef GM, Olsson AY. An update on human and mouse glandular kallikreins. Clinical Biochemistry. 37: 258-60. PMID 15003726 DOI: 10.1016/j.clinbiochem.2003.12.013  1
2003 Diamandis EP, Borgoño CA, Scorilas A, Yousef GM, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M. Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 24: 299-309. PMID 15004490 DOI: 10.1159/000076462  1
2003 Borgoño CA, Grass L, Soosaipillai A, Yousef GM, Petraki CD, Howarth DH, Fracchioli S, Katsaros D, Diamandis EP. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer. Cancer Research. 63: 9032-41. PMID 14695222  1
Show low-probability matches.